Cavia Model for Diabetes Mellitus (DM)

Diabetes

  • Product No.DSI521Gu02
  • Organism SpeciesCavia (Guinea pig ) Same name, Different species.
  • Prototype SpeciesHuman
  • SourceDrug Ⅰ diabetes
  • Model Animal StrainsGuinea pig, healthy, male and female, body weight 350g~700g.
  • Modeling GroupingRandomly divided into six group: Control group, Model group, Positive drug group and Test drug group.
  • Modeling Period4-6 weeks
  • Modeling MethodGuinea pigs by intraperitoneal injection according to the dose of 200 mg/kg body weight chain urea rhzomorph citrate buffer, 24 h after subcutaneous injection regularly every day long-term islet line 2 U in order to maintain the serum insulin levels, for six weeks.
  • Applicationsn/a
  • Download n/a
  • UOM Each case
  • FOB US$
    For more details, please contact local distributors!
  • Cavia Model for Diabetes Mellitus (DM) Packages (Simulation)
  • Cavia Model for Diabetes Mellitus (DM) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Model Evaluation of the Cavia Model for Diabetes Mellitus (DM)

Pathological Results of the Cavia Model for Diabetes Mellitus (DM)

Cytokines Level of the Cavia Model for Diabetes Mellitus (DM)

Statistical Analysis of the Cavia Model for Diabetes Mellitus (DM)

SPSS software is used for statistical analysis, measurement data to mean ± standard deviation (x ±ｓ), using t test and single factor analysis of variance for group comparison, P<0.05 indicates there was a significant difference, P<0.01 indicates there are very significant differences.

Related products

Catalog No. Organism species: Cavia (Guinea pig ) Applications (RESEARCH USE ONLY!)
DSI521Gu01 Cavia Model for Diabetes Mellitus (DM) n/a
DSI521Gu02 Cavia Model for Diabetes Mellitus (DM) n/a
GUESTBOOK